# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
JMP Securities analyst Daniel Stauder maintains Artivion (NYSE:AORT) with a Market Outperform and raises the price target fr...
On September 26, 2025, Artivion, Inc. (the "Company") entered into two Real Estate Purchase and Sale Contracts having s...
Stifel analyst Rick Wise maintains Artivion (NYSE: AORT) with a Buy and raises the price target from $40 to $46.
Across the recent three months, 7 analysts have shared their insights on Artivion (NYSE: AORT), expressing a variety of opinion...
Canaccord Genuity analyst William Plovanic maintains Artivion (NYSE: AORT) with a Buy and raises the price target from $41 t...
Needham analyst Mike Matson maintains Artivion (NYSE:AORT) with a Buy and raises the price target from $45 to $50.
Ladenburg Thalmann analyst Jeff Cohen downgrades Artivion (NYSE:AORT) from Buy to Neutral and raises the price target from $...
-SEC Filing